Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 5
2008 1
2009 2
2010 7
2011 8
2012 6
2013 7
2014 2
2015 8
2016 5
2017 6
2018 4
2019 6
2020 6
2021 5
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Seroprevalence of Bas-Congo virus in Mangala, Democratic Republic of the Congo: a population-based cross-sectional study.
Munyeku-Bazitama Y, Okitale-Talunda P, Hattori T, Saito T, Lombe BP, Miyamoto H, Mori-Kajihara A, Kajihara M, Nkoy AB, Twabela AT, Masumu J, Ahuka-Mundeke S, Muyembe-Tamfum JJ, Igarashi M, Park ES, Morikawa S, Makiala-Mandanda S, Takada A. Munyeku-Bazitama Y, et al. Among authors: igarashi m. Lancet Microbe. 2024 Mar 28:S2666-5247(24)00021-1. doi: 10.1016/S2666-5247(24)00021-1. Online ahead of print. Lancet Microbe. 2024. PMID: 38555924 Free article.
Targeting cap1 RNA methyltransferases as an antiviral strategy.
Tsukamoto Y, Igarashi M, Kato H. Tsukamoto Y, et al. Among authors: igarashi m. Cell Chem Biol. 2024 Jan 18;31(1):86-99. doi: 10.1016/j.chembiol.2023.11.011. Epub 2023 Dec 12. Cell Chem Biol. 2024. PMID: 38091983 Free article. Review.
Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain.
Tabata K, Itakura Y, Ariizumi T, Igarashi M, Kobayashi H, Intaruck K, Kishimoto M, Kobayashi S, Hall WW, Sasaki M, Sawa H, Orba Y. Tabata K, et al. Among authors: igarashi m. Appl Microbiol Biotechnol. 2023 Dec;107(24):7515-7529. doi: 10.1007/s00253-023-12817-5. Epub 2023 Oct 13. Appl Microbiol Biotechnol. 2023. PMID: 37831184 Free PMC article.
Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication.
Tsukamoto Y, Hiono T, Yamada S, Matsuno K, Faist A, Claff T, Hou J, Namasivayam V, Vom Hemdt A, Sugimoto S, Ng JY, Christensen MH, Tesfamariam YM, Wolter S, Juranek S, Zillinger T, Bauer S, Hirokawa T, Schmidt FI, Kochs G, Shimojima M, Huang YS, Pichlmair A, Kümmerer BM, Sakoda Y, Schlee M, Brunotte L, Müller CE, Igarashi M, Kato H. Tsukamoto Y, et al. Among authors: igarashi m. Science. 2023 Feb 10;379(6632):586-591. doi: 10.1126/science.add0875. Epub 2023 Feb 9. Science. 2023. PMID: 36758070
Efficacy and safety of desmopressin orally disintegrating tablets 25 and 50 μg in male patients with nocturia: A Japanese real-world multicenter clinical study.
Kyoda Y, Kimura M, Shimizu T, Miyao N, Ogasawara T, Shimizu T, Iwasawa A, Yorozuya W, Hashimoto J, Ichihara K, Takei F, Uchida K, Kouzen N, Suzuki N, Tachikawa K, Shibuya A, Muranaka I, Okada M, Igarashi M, Shibamori K, Nofuji S, Fujino K, Toyota T, Ito Y, Shinkai N, Hashimoto K, Kobayashi K, Tanaka T, Masumori N. Kyoda Y, et al. Among authors: igarashi m. Low Urin Tract Symptoms. 2022 Nov;14(6):410-415. doi: 10.1111/luts.12459. Epub 2022 Aug 5. Low Urin Tract Symptoms. 2022. PMID: 36319193
Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid Knockout Cells.
Kamiki H, Murakami S, Nishikaze T, Hiono T, Igarashi M, Furuse Y, Matsugo H, Ishida H, Katayama M, Sekine W, Muraki Y, Takahashi M, Takenaka-Uema A, Horimoto T. Kamiki H, et al. Among authors: igarashi m. J Virol. 2022 Aug 10;96(15):e0041622. doi: 10.1128/jvi.00416-22. Epub 2022 Jul 18. J Virol. 2022. PMID: 35862707 Free PMC article.
Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases.
Bergant V, Yamada S, Grass V, Tsukamoto Y, Lavacca T, Krey K, Mühlhofer MT, Wittmann S, Ensser A, Herrmann A, Vom Hemdt A, Tomita Y, Matsuyama S, Hirokawa T, Huang Y, Piras A, Jakwerth CA, Oelsner M, Thieme S, Graf A, Krebs S, Blum H, Kümmerer BM, Stukalov A, Schmidt-Weber CB, Igarashi M, Gramberg T, Pichlmair A, Kato H. Bergant V, et al. Among authors: igarashi m. EMBO J. 2022 Sep 1;41(17):e111608. doi: 10.15252/embj.2022111608. Epub 2022 Jul 25. EMBO J. 2022. PMID: 35833542 Free PMC article.
83 results